Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma Y Shi, SK Lim, Q Liang, SV Iyer, HY Wang, Z Wang, X Xie, D Sun, ... Nature 567 (7748), 341-346, 2019 | 255 | 2019 |
DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway A Parrales, A Ranjan, SV Iyer, S Padhye, SJ Weir, A Roy, T Iwakuma Nature cell biology 18 (11), 1233-1243, 2016 | 213 | 2016 |
MTBP suppresses cell migration and filopodia formation by inhibiting ACTN4 N Agarwal, AS Adhikari, SV Iyer, K Hekmatdoost, DR Welch, T Iwakuma Oncogene 32 (4), 462-470, 2013 | 94 | 2013 |
Wolcott‐Rallison syndrome: a clinical and genetic study of three children, novel mutation in EIF2AK3 and a review of the literature S Iyer, M Korada, L Rainbow, J Kirk, RM Brown, N Shaw, TG Barrett Acta paediatrica 93 (9), 1195-1201, 2004 | 89 | 2004 |
Genome-wide RNAi screening identifies TMIGD3 isoform1 as a suppressor of NF-κB and osteosarcoma progression SV Iyer, A Ranjan, HK Elias, A Parrales, H Sasaki, BC Roy, S Umar, ... Nature Communications 7 (1), 13561, 2016 | 34 | 2016 |
Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities SV Iyer, A Parrales, P Begani, A Narkar, AS Adhikari, LA Martinez, ... Oncotarget 7 (5), 5401, 2016 | 30 | 2016 |
Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression D Sun, XP Xie, X Zhang, Z Wang, SF Sait, SV Iyer, YJ Chen, R Brown, ... Cell Stem Cell 28 (8), 1397-1410. e4, 2021 | 25 | 2021 |
An improved intrafemoral injection with minimized leakage as an orthotopic mouse model of osteosarcoma H Sasaki, SV Iyer, K Sasaki, OW Tawfik, T Iwakuma Analytical biochemistry 486, 70-74, 2015 | 20 | 2015 |
MTBP inhibits the Erk1/2-Elk-1 signaling in hepatocellular carcinoma TI Atul Ranjan, Swathi V. Iyer, Christopher Ward, Tim Link, Francisco J ... Oncotarget 9 (30), 21429-21443, 2018 | 19* | 2018 |
A novel link between the HER2-Akt and MDM2-p53 pathways via CSN6 SV Iyer, T Iwakuma Cell Cycle 11 (22), 4112-4112, 2012 | 14 | 2012 |
Suppressive roles of A3AR and TMIGD3 i1 in osteosarcoma malignancy. IT Ranjan A, Iyer SV Cell Cycle, 2017 | 10 | 2017 |
Novel siRNA formulation to effectively knockdown mutant p53 in osteosarcoma AK Kundu, SV Iyer, S Chandra, AS Adhikari, T Iwakuma, TK Mandal PLoS One 12 (6), e0179168, 2017 | 9 | 2017 |
Abstract B031: A brain penetrant Nicotinamide-adenine dinucleotide mimetic impedes de novo guanylate synthesis and glioblastoma growth YJ Chen, SV Iyer, CC David Hsieh, T Wang, J Li, MC Lien, M Ganbold, ... Cancer Research 84 (5_Supplement_1), B031-B031, 2024 | | 2024 |
PATH-09. THE SEARCH FOR A NOVEL SUBTYPE OF GLIOBLASTOMA AND ITS CELL-OF-ORIGIN YJ Chen, S Iyer, X Xie, L Parada Neuro-Oncology 23 (Suppl 6), vi116, 2021 | | 2021 |
Abstract B24: Regulation of mutant p53 stability by the mevalonate pathway-Hsp40-CHIP axis A Parrales, A Ranjan, SV Iyer, S Weir, A Roy, T Iwakuma Clinical Cancer Research 23 (1_Supplement), B24-B24, 2017 | | 2017 |
Metabolic regulation of mutant p53 stability by the mevalonate pathway T Iwakuma, A Ranjan, SV Iyer, S Padhye, S Weir, A Roy Cancer Research 76 (14_Supplement), 3690-3690, 2016 | | 2016 |
ROLES OF TMIGD3 AND A3AR IN SUPPRESSION OF OSTEOSARCOMA MALIGNANCY SV Iyer University of Kansas, 2016 | | 2016 |
Functional association of MDM2 Binding Protein with migratory and metastatic potential of hepatocellular carcinoma. Q Bi, R Fan, N Agarwal, SV Iyer, J Ding, T Iwakuma Cancer Research 73 (8_Supplement), 3874-3874, 2013 | | 2013 |
Abstract C43: Functional association of MDM2 binding protein with migratory and metastatic potential of hepatocellular carcinoma Q Bi, R Fan, N Agarwal, SV Iyer, J Ding, T Iwakuma Cancer Research 73 (3_Supplement), C43-C43, 2013 | | 2013 |
Quiescent Stem-Like Cells Drive NF1-Associated MPNST Functional Heterogeneity and Tumor Progression D Sun, X Xie, X Zhang, Z Wang, S Farouk-Sait, SV Iyer, YJ Chen, R Brown, ... Available at SSRN 3732377, 0 | | |